TP53 and Patent ductus arteriosus: The iKras* mice represent an early lesion timepoint, whereas the iKras* p53* mice, which have a pancreas specific mutated p53, represent a late lesion timepoint, allowing us to evaluate Chil-TAMs and Cq-TAMs during progression of PDA.